Patents by Inventor Mukteeshwar Gande

Mukteeshwar Gande has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Reduced dose metaxalone formulations
    Patent number: 11918559
    Abstract: Oral dosage forms of metaxalone having improved bioavailability in the fed and fasted states, including dosage forms that employ a reduced dose based on such improved bioavailability.
    Type: Grant
    Filed: May 14, 2023
    Date of Patent: March 5, 2024
    Assignee: Primus Pharmceuticals, Inc.
    Inventors: Mukteeshwar Gande, Robert M. Levy
  • Reduced Dose Metaxalone Formulations
    Publication number: 20230310387
    Abstract: Oral dosage forms of metaxalone having improved bioavailability in the fed and fasted states, including dosage forms that employ a reduced dose based on such improved bioavailability.
    Type: Application
    Filed: May 14, 2023
    Publication date: October 5, 2023
    Inventors: Mukteeshwar Gande, Robert M. Levy
  • REDUCED DOSE METAXALONE FORMULATIONS
    Publication number: 20200405693
    Abstract: Oral dosage forms of metaxalone having improved bioavailability in the fed and fasted states, including dosage forms that employ a reduced dose based on such improved bioavailability.
    Type: Application
    Filed: July 29, 2019
    Publication date: December 31, 2020
    Inventors: Mukteeshwar Gande, Robert M. Levy
  • CARBAMAZEPINE EXTENDED RELEASE DOSAGE FORM
    Publication number: 20090169619
    Abstract: Extended release pharmaceutical dosage forms of carbamazepine for oral administration to maintain a patient's blood concentration for at least a 12 hour period, methods of administering dosage forms and processes for the preparation of such dosage form.
    Type: Application
    Filed: March 9, 2009
    Publication date: July 2, 2009
    Applicant: CorePharma LLC
    Inventors: Mukteeshwar Gande, Rasik Gondalia, Madhusudanarao Kothapalli, Naga Mahendar Velishala, Vamsi Koppuri
  • Stabilized composition of ticlopidine hydrochloride
    Patent number: 5872128
    Abstract: A novel pharmaceutical composition including thieno-pyridine derivatives, primarily ticlopidine hydrochloride, having no other organic or inorganic acid stabilizing agents or metal stearates. The stable pharmaceutical composition also includes hydrogenated vegetable oil as lubricant and other suitable non-ionic inert pharmaceutical excipients.
    Type: Grant
    Filed: October 15, 1997
    Date of Patent: February 16, 1999
    Assignee: Invamed, Inc.
    Inventors: Mahendra Patel, Mukteeshwar Gande, Pankaj Dave, Madhava Reddy Uppugalla